Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Election of the Board of Directors on the annual general meeting

Posted on: 30 Apr 18

Company announcement
30 April 2018

On 27 April 2018, NeuroSearch A/S ("NeuroSearch") received a notice from Gefion Group Investments A/S ("Gefion") that Gefion had decided to launch a conditional, voluntary takeover offer to the shareholders of NeuroSearch to acquire the entire share capital of NeuroSearch (excluding any treasury shares), as made public by company announcement no. 6 on 27 April 2018 (the "Offer").

Considering the Offer, the directors of NeuroSearch are prepared to be re-elected on NeuroSearch's annual general meeting to be held today 30 April 2018 with a view to clarify and, if relevant, complete the process of the Offer.

Contact person:

Allan Andersen, CEO, +45 4016 3864

About NeuroSearch
NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.



Last updated on: 30/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.